Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase?

References

• Aho K., Palosuo T., Raunio V., Puska P., Aromaa A., Salonen J. T. When does rheumatoid disease start?. Arthritis Rheum 1985; 28: 485–9
   PubMed Web of Science ®Google Scholar
• Aho K., Palosuo T., Niemela N., Takala J. Rheumatoid factor seroconversions in relation to clinical rheumatoid arthritis. Ann Clin Res 1985; 17: 15–18
   PubMedGoogle Scholar
• Aho K., Heliovaara M., Maatela J., Tuomi T., Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991; 18: 1282–4
   PubMed Web of Science ®Google Scholar
• Aho K., von Essen R., Kurki P., Palosuo T., Heliovaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993; 20: 1278–81
   PubMed Web of Science ®Google Scholar
• Rantapaa‐Dahlqvist S. Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 2005; 34: 83–96
   PubMed Web of Science ®Google Scholar
• Aho K., Palosuo T., Heliovaara M., Knekt P., Alha P., von Essen R. Antifilaggrin antibodies within “normal” range predict rheumatoid arthritis in a linear fashion. J Rheumatol 2000; 27: 2743–6
   PubMed Web of Science ®Google Scholar
• Rantapaa‐Dahlqvist S., de Jong B. A. W., Berglin E., Hallmans G., Wadell G., Stenlund H., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741–9
   PubMed Web of Science ®Google Scholar
• Nielen M. M., van Schaardenburg D., Reesink H. W., van de Stadt R. J., van der Horst‐Bruinsma I. E., de Koning M. H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380–6
   PubMed Web of Science ®Google Scholar
• Klareskog L., Alfredsson L., Rantapaa‐Dahlqvist S., Berglin E., Stolt P., Padyukov L. What precedes development of rheumatoid arthritis?. Ann Rheum Dis 2004; 63(Suppl 2)ii28–31
   PubMed Web of Science ®Google Scholar
• Hasstedt S. J., Clegg D. O., Ingles L., Ward R. H. HLA‐linked rheumatoid arthritis. Am J Hum Genet 1994; 55: 738–46
   PubMed Web of Science ®Google Scholar
• Kwoh C. K., Venglish C., Lynn A. H., Whitley D. M., Young E., Chakravarti A. Age, sex, and the familial risk of rheumatoid arthritis. Am J Epidemiol 1996; 144: 15–24
   PubMed Web of Science ®Google Scholar
• Heliovaara M., Aho K., Aromaa A., Knekt P., Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993; 20: 1830–5
   PubMed Web of Science ®Google Scholar
• Uhlig T., Hagen K. B., Kvien T. K. Current tobacco smoking, formal education and the risk of rheumatoid arthritis. J Rheumatol 1999; 26: 47–54
   PubMed Web of Science ®Google Scholar
• Stolt P., Bengtsson C., Nordmark B., Lindblad S., Lundberg I., Klareskog L., et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis; results from a population based case–control study, using incident cases. Ann Rheum Dis 2003; 62: 835–41
   PubMed Web of Science ®Google Scholar
• Masi A. T., Chang H. J. Cigarette smoking and other acquired risk factors for rheumatoid arthritis. Rheumatic diseases and the environment, L. D Kaufman, J Varga. Chapman & Hall, New York 1999; 111–27
   Google Scholar
• Aho K., Heliovaara M. Risk factors for rheumatoid arthritis. Ann Med 2004; 36: 242–51
   PubMed Web of Science ®Google Scholar
• Reckner Olsson A., Skogh T., Wingren G. Aetiological factors of importance for the development of rheumatoid arthritis. Scand J Rheumatol 2004; 33: 300–6
   PubMed Web of Science ®Google Scholar
• Laskin M. D., Pope J. E., Krizova A., Ouimet J. M., Goodwin J. L. Are infections increased in rheumatoid arthritis (RA) prior to diagnosis? Results of a case control study of RA compared to non‐inflammatory musculoskeletal disorders. Scand J Rheumatol 2005; 34: 74–8
   PubMed Web of Science ®Google Scholar
• Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–13
   PubMed Web of Science ®Google Scholar
• Choy E. H. S., Panayi G. S. Mechanisms of disease: cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907–16
   PubMed Web of Science ®Google Scholar
• Chrousos G. P. The hypothalamic–pituitary–adrenal axis and immune‐mediated inflammation. N Engl J Med 1995; 332: 1351–62
   PubMed Web of Science ®Google Scholar
• Masi A. T., Feigenbaum S. L., Chatterton R. T., Cutolo M. Integrated hormonal–immunological–vascular (“H–I–V” triad) systems interactions in rheumatic diseases. Clin Exp Rheumatol 1995; 13: 203–16
   PubMed Web of Science ®Google Scholar
• Masi A. T., Feigenbaum S. L., Chatterton R. T. Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. Semin Arthritis Rheum 1995; 25: 1–27
   PubMed Web of Science ®Google Scholar
• Masi A. T., Bijlsma J. W. J., Chikanza I. C., Pitzalis C., Cutolo M. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum 1999; 29: 65–81
   PubMed Web of Science ®Google Scholar
• Masi A. T. Hormonal and immunologic risk factors for the development of rheumatoid arthritis: an integrative physiopathogenetic perspective. Rheum Dis Clin N Am 2000; 26: 775–803
   PubMed Web of Science ®Google Scholar
• Straub R. H., Besedovsky H. O. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J 2003; 17: 2176–83
   PubMed Web of Science ®Google Scholar
• Masi A. T., Aldag J. C., Jacobs J. W. G. Rheumatoid arthritis: neuroendocrine immune integrated physiopathogenetic perspectives and therapy. Rheum Dis Clin N Am 2005; 31: 131–60
   PubMed Web of Science ®Google Scholar
• Masi A. T., DaSilva J. A. P., Cutolo M. Perturbations of hypothalamic–pituitary–gonadal (HPG) axis and adrenal androgen (AA) functions in rheumatoid arthritis. Bailliere's Clin Rheum 1996; 10: 295–332
   PubMed Web of Science ®Google Scholar
• Haskard D. O. Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 2004; 33: 281–92
   PubMed Web of Science ®Google Scholar
• Wallberg‐Jonsson S., Ohman M. ‐L., Rantapaa‐Dahlqvist S. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?. Scand J Rheumatol 2004; 33: 373–9
   PubMed Web of Science ®Google Scholar
• Alkaabi J. K., Ho M., Levison R., Pullar T., Belch J. J. Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) 2003; 42: 292–7
   PubMed Web of Science ®Google Scholar
• Hetland M. L., Skjodt H., Ostergaard M., Nielsen H. J., Johansen J. S. Initial levels and early changes in plasma VEGF correlate closely with long‐term clinical outcome in RA patients treated with TNF‐alfa antagonists. Abstract 0159. Ann Rheum Dis 2003; 62(Suppl 1)
   Google Scholar
• Gedeit R. G. Tumor necrosis factor‐alpha induces E‐selectin expression on vascular endothelial cells. Crit Care Med 1996; 24: 1543–6
   PubMed Web of Science ®Google Scholar
• Mojcik C. F., Shevach E. M. Adhesion molecules. A rheumatologic perspective. Arthritis Rheum 1997; 40: 991–1004
   PubMed Web of Science ®Google Scholar
• Hurlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., et al. Anti‐tumor necrosis factor‐alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002; 106: 2184–7
   PubMed Web of Science ®Google Scholar
• Liu D., Dillon J. S. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 2004; 69: 279–89
   PubMed Web of Science ®Google Scholar
• Masi A. T., Medsger T. A Jr. Epidemiology of the rheumatic diseases. Arthritis and allied conditions, 11th edn, D. J McCarty. Lea & Febiger, Philadelphia 1989; 16–54
   Google Scholar
• Masi A. T. Incidence of rheumatoid arthritis: do the observedage–sex interaction patterns support a role of androgenic–anabolic steroid deficiency in its pathogenesis?. Br J Rheumatol 1994; 33: 697–9
   PubMedGoogle Scholar
• Hench P. S. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Proc Mayo Clin 1938; 13: 161–7
   Google Scholar
• Cutolo M., Villaggio B., Foppiani L., Briata M., Sulli A., Pizzorni C., et al. The hypothalamic–pituitary–adrenal and gonadal axes in rheumatoid arthritis. Ann N Y Acad Sci 2000; 917: 835–43
   PubMed Web of Science ®Google Scholar
• Straub R. H., Cutolo M. Involvement of the hypothalamic–pituitary–adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001; 44: 493–507
   PubMed Web of Science ®Google Scholar
• Cutolo M., Villaggio B., Craviotto C., Pizzorni C., Seriolo B., Sulli A. Sex hormones and rheumatoid arthritis. Autoimmun Rev 2002; 1: 284–9
   PubMedGoogle Scholar
• Straub R. H., Scholmerich J., Cutolo M. The multiple facets of premature aging in rheumatoid arthritis. Arthritis Rheum 2003; 48: 2713–21
   PubMed Web of Science ®Google Scholar
• Tuomilehto J., Lindstrom J., Eriksson J. G., Valle T. T., Hamalainen H., Ilanne Parikka R., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–50
   PubMed Web of Science ®Google Scholar
• Bergman R. N. Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med 2002; 69: 280–90
   PubMedGoogle Scholar
• Knowler W. C., Barrett‐Connor E., Fowler S. E., Hamman R. F., Lachin J. M., Walker E. A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403
   PubMed Web of Science ®Google Scholar
• Benjamin S. M., Valdez R., Geiss L. S., Rolka D. B., Narayan K. M. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 2003; 26: 645–9
   PubMed Web of Science ®Google Scholar
• Lowensteyn I., Joseph L., Levinton C., Abrahamowicz M., Steinert Y., Grover S. Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med 1998; 27: 730–7
   PubMed Web of Science ®Google Scholar
• Liao Y. McGee DL. Cooper RS. Sutkowski MB. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J 1999; 137: 837–45
   PubMed Web of Science ®Google Scholar
• Snyderman R., Williams R. S. Prospective medicine: the next health care transformation. Acad Med 2003; 78: 1079–84
   PubMed Web of Science ®Google Scholar
• Hood L., Heath J. R., Phelps M. E., Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004; 306: 640–3
   PubMed Web of Science ®Google Scholar
• Framingham Heart Study: You changed America's heart. http://www.nhlbi.nih.gov/about/framingham/fhsbro.pdf
   Google Scholar
• Braitman L. E., Davidoff F. Predicting clinical states in individual patients. Ann Intern Med 1996; 125: 406–12
   PubMed Web of Science ®Google Scholar
• Burch P. R. J. A genetic theory of inflammatory polyarthritis. Lancet 1963; 1, 2: 1253, 636–7
   Google Scholar
• Harris E. D Jr. Rheumatoid arthritis. WB Saunders, Philadelphia 1997
   Google Scholar
• Ollier W., Winchester R. The germline and somatic genetic basis for rheumatoid arthritis. Curr Dir Autoimmun 1999; 1: 166–93
   PubMedGoogle Scholar
• Dieppe P. Strategies for the prevention of osteoarthritis. Int J Tissue React 1993; 15: 93–7
   PubMedGoogle Scholar
• Felson D. T., Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998; 41: 1343–55
   PubMed Web of Science ®Google Scholar
• Choi H. K., Atkinson K., Karlson E. W., Willett W., Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277–81
   PubMed Web of Science ®Google Scholar
• Masi A. T., Josipovic D. B., Jefferson W. E. Low adrenal androgenic–anabolic steroids in women with rheumatoid arthritis (RA): gas–liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11‐deoxy‐17‐ketosteroid excretion. Semin Arthritis Rheum 1984; 14: 1–23
   PubMed Web of Science ®Google Scholar
• Masi A. T., Aldag J. C., Chatterton R. T., Adams R. F., Kitabchi A. E. Adrenal androgen and glucocorticoid dissociation in premenopausal rheumatoid arthritis: a significant correlate or precursor to onset?. Z Rheumatol 2000; 59(Suppl 2)54–61
   Google Scholar
• Helzlsouer K. J., Alberg A. J., Gordon G. B., Longcope C., Bush T. L., Hoffman S. C., et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. J Am Med Assoc 1995; 274: 1926–30
   PubMed Web of Science ®Google Scholar
• Rothman N., Cantor K. P., Blair A., Bush D., Brock J. W., Helzlsouer K., et al. A nested case–control study of non‐Hodgkin lymphoma and serum organochlorine residues. Lancet 1997; 350: 240–4
   PubMed Web of Science ®Google Scholar
• Alberg A. J., Gordon G. B., Hoffman S. C., Comstock G. W., Helzlsouer K. J. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 517–21
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Masi A. T., Chatterton R. T., Comstock G. W., Malamet R. L., Hochberg M. C. Decreased serum dehydroepiandrosterone sulfate (DHAS) levels before onset of RA in younger, premenopausal women: a controlled, prospective study. Arthritis Rheum 1994; 37(Suppl 315)
   Google Scholar
• Masi A. T., Chatterton R. T., Aldag J. C., Comstock G. W., Helzlsouer K. J., Hoffman S. C., et al. Decreased serum dehydroepiandrosterone sulfate (DHEAS) levels in menstruating women prior to onset of RA before age 50: independent reference laboratory assays validate previous significant results. Arthritis Rheum 1998; 41(Suppl 126)
   PubMed Web of Science ®Google Scholar
• Masi A. T., Chatterton R. T., Aldag J. C., Malamet R. L. Perspectives on the relationship of adrenal steroids to rheumatoid arthritis. Ann N Y Acad Sci 2002; 966: 1–12
   PubMed Web of Science ®Google Scholar
• Masi A. T., Chatterton R. T., Lu Y. C., Comstock G. W., Malamet R. L., Hochberg M. C., et al. Low serum dehydroepiandrosterone sulfate (DHAS) levels, rheumatoid factor (RF) and elevated serum tumor necrosis factor α (TNFα) without cytokine receptor (CR) elevations predict long‐term onset of RA in women: a controlled, prospective study. Arthritis Rheum 1995; 38(Suppl 214)
   Google Scholar
• Masi A. T., Chatterton R. T., Comstock G. W., Helzlsouer K. J., Hoffman S. C., Malamet R. L., et al. A positive history of rheumatoid arthritis (RA) in a first degree relative (FDR) or a positive serological predictor for RA prior to disease onset before age 50 were uniformly present in a sample of younger, premenopausal incident cases: results of a prospective, controlled study. Arthritis Rheum 1998; 41(Suppl 126)
   PubMed Web of Science ®Google Scholar
• Lobo R. A., Paul W. L., Goebelsmann U. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function. Obstet Gynecol 1981; 57: 69–73
   PubMed Web of Science ®Google Scholar
• Kabowiak I., Petrillo G., Zovato S., Sinsoncini M., Eottardo C., Scaroni C., et al. Relationships between serum dehydroepiandrosterone sulphate, cortisol and age in healthy women [Abstract P2‐654]. ENDO, The Endocrine Society Program and Abstracts 1998; 385
   Google Scholar
• Masi A. T., Chatterton R. T., Fecht T., Aldag J. C., Comstock G. W., Helzlsour K. J., et al. Dissociation of serum dehydroepiandrosterone sulfate (DHEAS) and cortisol levels in younger premenopausal women prior to onset of rheumatoid arthritis (RA) before age 50: results of a prospective, controlled study. Arthritis Rheum 1998; 41(Suppl 126)
   PubMed Web of Science ®Google Scholar
• Masi A. T., Chrousos G. P., Bornstein S. R. Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis. J Rheumatol 1999; 26: 247–250
   PubMed Web of Science ®Google Scholar
• Merlino L. A., Cerhan J. R., Criswell L. A., Mikuls T. R., Saag K. G. Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum 2003; 33: 72–82
   PubMed Web of Science ®Google Scholar
• Masi A. T., Chrousos G. P. Polycystic ovarian syndrome and rheumatoid arthritis: possible physiopathogenetic clues to hormonal influences on chronic inflammation. Semin Arthritis Rheum 2003; 33: 67–71
   PubMed Web of Science ®Google Scholar
• Masi A. T., Aldag J. C., Malamet R. L., Sipe J. D., Teodorescu M., Peter J. B., et al. Heavy smoking of 30+ cigarettes daily (HS 30+/d) significantly predicted onset of rheumatoid arthritis (RA) in both genders, and was an independent risk factor from either rheumatoid factor positivity (RF+) or development of the disease in a first degree relative (FDR+). Arthritis Rheum 2001; 44(Suppl 105)
   Google Scholar
• Masi A. T., Aldag J. C., Malamet R. L., Peter J. B. Perturbations in serum levels of interleukin‐1 beta (IL‐1β) and IL‐1 receptor antagonist (IL‐1Ra) before clinical rheumatoid arthritis (pre‐RA) in women with younger versus older onset. Arthritis Rheum 2002; 45(Suppl 101)
   Google Scholar
• Masi A. T., Fecht T., Aldag J. C., Comstock G. W., Hoffman S., Malamet R. L. History of currently smoking cigarettes, but not years of education, correlated with the subsequent development of rheumatoid arthritis: preliminary findings from a community‐wide, prospective, nested, case–control study. Arthritis Rheum 1996; 39(Suppl 301)
   Google Scholar
• Masi A. T., Aldag J. C., Cooling M. B., Chatterton R. T., Sipe J. D., Malamet R. L. Cigarette smoking increased rheumatoid arthritis risks in postmenopausal women and men independently of baseline C‐reactive protein (CRP) and prolactin (PRL) levels. Arthritis Rheum 2003; 48(Suppl 394)
   Google Scholar
• Masi A. T., Aldag J. C., Cooling M. B., Chatterton R. T., Malamet R. L. Rheumatoid arthritis risks were not affected by baseline serum prolactin (PRL), cortisol (C), or PRL:C ratio levels prior to clinical onset (pre‐RA) in postmenopausal women or men. Arthritis Rheum 2003; 48: S394
   Google Scholar
• Masi A. T., Aldag J. C., Fecht T., Teodorescu M., Sipe J. D., Agopian M. S. Rheumatoid factor positivity (RF+) and current cigarettes smoking (CCS+) of 30+ daily are independent, long‐term predictors of RA. Arthritis Rheum 1997; 40(Suppl 312)
   Google Scholar
• Masi A. T., Aldag J. C., Chatterton R. T., Malamet R. L., Comstock G. W., Helzlsour K. J., et al. Precursor risk markers (RMs) were identified in 94% of 18 pre‐rheumatoid arthritis (pre‐RA) males compared to 28% of 72 matched controls (CN) in a community‐based, prospective study. Arthritis Rheum 2000; 43(Suppl 167)
   Google Scholar
• Masi A. T., Aldag J. C., Chatterton R. T., Teodorescu M., Malamet R. L., Comstock G. W., et al. Independent risk markers (RMs) for RA onset in males include: rheumatoid arthritis (RA) in a first degree relative (FDR+); rheumatoid factor (RF+); combined low serum cortisol and testosterone (low C&T), and heavy cigarette smoking (CS 30+/d). Arthritis Rheum 2000; 43(Suppl 70)
   Google Scholar
• Masi A. T., Chatterton R. T., Comstock G. W., Malamet R. L., Hochberg M. C. Decreased androgenic–anabolic (AA) hormone levels in sera of white women before onset of RA: a controlled, prospective study. Arthritis Rheum 1993; 36(Suppl 176)
   Google Scholar
• Masi A. T., Aldag J. C., Malamet R. L., Sipe J. D., Teodorescu M., Peter J. B., et al. Elevated serum C‐reactive protein (CRP+) significantly associated with elevated serum rheumatoid factors (RF+) in male rheumatoid arthritis long before onset of clinical disease (pre‐RA), but not in controls. Arthritis Rheum 2001; 44(Suppl 105)
   Google Scholar
• Masi A. T., Aldag J. C., Pirzada F. A., Pirzada N., Chatterton R. T., Malamet R. L., et al. Serum hormone and biological mediator correlations were found many years before onset of rheumatoid arthritis (RA) in 18 pre‐RA males, but not in 72 matched controls (CN). Arthritis Rheum 2000; 43(Suppl 158)
   Google Scholar
• Masi A. T., Aldag J. C., Chatterton R. T., Malamet R. L. Basal serum IL‐1β correlations with glucocorticoid precursor and sex steroid levels differed significantly in men and women before onset of rheumatoid arthritis (pre‐RA) versus their matched controls. Arthritis Rheum 2004; 50(Suppl)352–3
   Google Scholar
• Schafer J. L. Imputation of missing covariates under a general linear mixed model. Technical report, Department of Statistics, Penn State University. 1997
   Google Scholar
• Demirtas H. Simulation driven inferences for multiply imputated longitudinal datasets. Stat Neerl 2004; 58: 466–82
   Web of Science ®Google Scholar
• Schafer J. L. Analysis of incomplete multivariate data. Chapman & Hall, London 1997
   Google Scholar
• Schafer J. L. Multiple imputation: a primer. Stat Methods Med Res 1999; 8: 3–5
   PubMed Web of Science ®Google Scholar
• SPSS (v13.0) for Windows. Chicago, SPSS Inc., 2004
   Google Scholar
• Rothman K. J., Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005; 95(Suppl)144–50
   Web of Science ®Google Scholar
• Volg D., Falk W., Dorner M., Scholmerich J., Straub R. H. Serum levels of pregnenolone and 17‐hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones. J Rheumatol 2003; 30: 269–75
   PubMed Web of Science ®Google Scholar
• Straub R. H., Pongratz G., Scholmerich J., Kees F., Schaible T. F., Antoni C., et al. Long‐term anti‐tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis Rheum 2003; 48: 1504–12
   PubMed Web of Science ®Google Scholar
• Straub R. H., Harle P., Atzeni F., Weidler C., Cutolo M., Sarzi‐Puttini P. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti‐tumor necrosis factor therapy. J Rheumatol 2005; 32: 1253–7
   PubMed Web of Science ®Google Scholar
• Masi A. T., Aldag J. C., Chatterton R. T., Malamet R. L. Basal steroidogenesis was normal before clinical onset of rheumatoid arthritis (pre‐RA) in postmenopausal women and men, despite marked differences by gender, and gender dimorphisms of correlations with TNF‐alpha. Arthritis Rheum 2003; 48(Suppl 344)
   Google Scholar
• McEwen B. S. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171–9
   PubMed Web of Science ®Google Scholar
• StClair E. W., Pisetsky D. S., Haynes B. F editors. Rheumatoid arthritis. Lippincott Williams & Wilkins, Philadelphia 2004
   Google Scholar